Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLEC-12A Inhibitors

CLEC-12A inhibitors, as a chemical class, encompass a diverse array of compounds that can modulate various signaling pathways, potentially affecting the function of CLEC-12A indirectly. These chemicals are not specific to CLEC-12A but can influence the wider signaling networks within which CLEC-12A operates. Protein kinase inhibitors like Staurosporine and U0126 can impede the phosphorylation cascades that are crucial for the propagation of signals from surface receptors such as CLEC-12A. By inhibiting these kinases, these compounds can alter the phosphorylation state of proteins involved in the downstream signaling of CLEC-12A, thereby modulating the receptor's functional outcomes. Similarly, PI3K inhibitors such as LY294002 and Wortmannin can disrupt the phosphatidylinositol 3-kinase pathway, which is often implicated in the regulation of immune responses and may intersect with CLEC-12A-mediated signaling.

Inhibitors of MAPK pathways, including SB203580, PD98059, and SP600125, target different components of the mitogen-activated protein kinase cascades. These cascades are involved in transmitting a wide variety of signals within cells, which could include those related to CLEC-12A. By modulating these pathways, the listed inhibitors can affect the cellular responses that CLEC-12A would typically mediate. Compounds like Rapamycin and Imatinib have broader targets, such as mTOR and tyrosine kinases, respectively. These enzymes play pivotal roles in cell growth, proliferation, and survival, and their inhibition can lead to changes in the cellular context within which CLEC-12A operates. Src family kinases, targeted by inhibitors like PP2, are implicated in numerous signal transduction processes, and their inhibition can also affect CLEC-12A-related signaling. Lastly, inhibitors such as BAY 11-7082 that target the NF-κB pathway can perturb a key transcription factor involved in the regulation of immune responses. By doing so, this inhibitor can impact the functional roles played by CLEC-12A in the immune system.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent protein kinase inhibitor that can affect signal transduction involved in CLEC-12A downstream effects.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can impact signaling pathways associated with CLEC-12A-mediated immune responses.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

An inhibitor of MEK, which is upstream of ERK in the MAPK pathway, potentially affecting CLEC-12A signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAPK, which may be involved in signaling cascades affecting CLEC-12A functions.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor which can modulate signaling pathways that intersect with CLEC-12A-related processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor that can disrupt signaling pathways involved in CLEC-12A-mediated functions.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

A specific inhibitor of MEK, which may alter ERK pathway activation related to CLEC-12A.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can affect the signaling involved in cellular processes regulated by CLEC-12A.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

A tyrosine kinase inhibitor that can impact signal transduction pathways associated with CLEC-12A.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Src family kinase inhibitor that may influence signaling pathways linking to CLEC-12A activity.